Cytomegalovirus-Induced Gastrointestinal Bleeding and Pancreatitis Complicating Severe Covid-19 Pneumonia: a Paradigmatic Case.

Main Article Content

Giacomo Marchi
Alice Vianello
Ernesto Crisafulli
Alessio Maroccia
Stefano Francesco Crinò
Sara Pecori
Giulia A Zamboni
Fulvia Mazzaferri
Evelina Tacconelli
Domenico Girelli


cytomegalovirus, sars-cov-2


Key points:

  • COVID-19 is a novel pandemic disease whose pathophysiology and clinical description are still not completely defined.

  • Besides respiratory symptoms, gastrointestinal (GI) symptoms (especially including anorexia, diarrhea, and abdominal pain) represent the commonest clinical manifestations.

  • Emerging data point out that severe SARS-CoV-2 infection causes an immune dysregulation, which in turn may favor other infections.

  • Here we describe a patient with severe COVID-19 pneumonia who developed in the resolving phase abdominal pain associated to cytomegalovirus (CMV)-induced duodenitis with bleeding, and pancreatitis.

  • A high level of suspicion toward multiple infections, including CMV, should be maintained in COVID-19 patients with heterogeneous clinical manifestations.


Download data is not yet available.

Abstract 864
PDF Downloads 682
HTML Downloads 155


1. Cheung KS, Hung IF, Chan PP, Lung K, Tso E, Liu R, Ng Y, Chu MY, Chung TW, Tam AR, Yip CC, Leung K-H, Yim-Fong Fung A, Zhang RR, Lin Y, Cheng HM, Zhang AJ, To KK, Chan K-H, Yuen K-Y, Leung WK (2020) Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples from the Hong Kong Cohort and Systematic Review and Meta-analysis. Gastroenterology, doi:
2. Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol;203(2):631-637
3. Gu J, Han B, Wang J (2020) COVID-19: Gastrointestinal Manifestations and Potential Fecal–Oral Transmission. Gastroenterology. doi: 10.1053/j.gastro.2020.02.054
4. Tian Y, Rong L, Nian W, He Y (2020) Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther;51(9):843-851. doi: 10.1111/apt.15731. Epub 2020 Mar 31.
5. Liu F, Long X, Zou W, Fang M, Wu W, Li W, Zhang B, Zhang W, Chen X, Xhang Z (2020) Highly ACE2 Expression in Pancreas May Cause Pancreas Damage After SARS-CoV-2 Infection. Medrxiv. doi:
6. Beattie RM, Ashton JJ, Penman ID (2020) COVID-19 and the gastrointestinal tract: emerging clinical data. Frontline Gastroenterology. doi:10.1136/flgastro-2020-101507
7. Emery VC (2001) Investigation of CMV disease in immunocompromised patients. J Clin Pathol;54:84–88
8. Perdan-Pirkmajer K, Koren-Kranjc M, Tomsic M. A successfully treated pancreatitis caused by a CMV infection in a lupus patient. Lupus 2011;20(10):1104-5.
9. Terada T (2011) Cytomegalovirus-associated severe fatal necrotizing pancreatitis in a patient with interstitial pneumonitis treated with steroids. An autopsy case. JOP;12(2):158-61.
10. Kamalkumar BS, Agarwal SK, Garg P, Dinda A, Tiwari SC (2009) Acute pancreatitis with CMV papillitis and cholangiopathy in a renal transplant recipient. Clin Exp Nephrol;13(4):389-91
11. Sakakibara Y, Nakazuru S, Kodama Y, Mita E (2017) Acute pancreatitis caused by cytomegalovirus-associated duodenal papillitis. Annals of Gastroenterology. DOI:
12. Li H, Liu L, Zhang D, Xu J, Dai H, Tang N, Su X, Cao B (2020) SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet
13. Giamarellos-Bourboulis EJ, Netea MG, Rovina N, Akinosoglou K, Antoniadou A, Antonakos N, et al. (2020) Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure. Cell Host & Microbe
14. Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB (2020) Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19) A Review. JAMA. doi:10.1001/jama.2020.6019

Similar Articles

You may also start an advanced similarity search for this article.